Form 8-K - Current report:
SEC Accession No. 0001213900-24-067670
Filing Date
2024-08-12
Accepted
2024-08-12 16:10:09
Documents
15
Period of Report
2024-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0211036-8k_therape.htm   iXBRL 8-K 26858
2 PRESS RELEASE FROM THERAPEUTICSMD, INC., DATED AUGUST 12, 2024, ENTITLED "THERAP ea021103601ex99-1_therape.htm EX-99.1 13098
6 GRAPHIC ex99-1_001.jpg GRAPHIC 4835
  Complete submission text file 0001213900-24-067670.txt   224979

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE txmd-20240812.xsd EX-101.SCH 3033
4 XBRL LABEL FILE txmd-20240812_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE txmd-20240812_pre.xml EX-101.PRE 22371
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0211036-8k_therape_htm.xml XML 3679
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-00100 | Film No.: 241196852
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)